First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes

Prenatal Diagnosis

Volumn 28, Issue 2, 2008, Pages 121-125

  Cowans, Nicholas J ^a   Spencer, Kevin ^a,b   Meiri, Hamutal ^c  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c Diagnostic Technologies Ltd   (Israel)

Author keywords

Fetal death; Intrauterine growth restriction; Low birth weight; Macrosomia; Preterm delivery

Indexed keywords

PLACENTA PROTEIN; PLACENTAL PROTEIN 13; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ETHNICITY; FEMALE; FETUS; FETUS DEATH; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL SERUM; PLACENTA; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SMALL FOR DATE INFANT; SMOKING; STATISTICAL SIGNIFICANCE;

EID: 39749085734     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1921     Document Type: Article

References (18)

1. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. 1993. Fetal nutrition and cardiovascular disease in adult life. Lancet 341 (8850): 938–941.
2. Bernstein IM, Mongeon JA, Badger GJ, Solomon L, Heil SH, Higgins ST. 2005. Maternal smoking and its association with birth weight. Obstet Gynecol 106 (5Pt1): 986–991.
3. Burger O, Pick E, Zwickel J, et al. 2004. Placental protein 13 (PP‐13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 25 (7): 608–622.
4. Chafetz I, Kuhnreich I, Sammar M, et al. 2007. First‐trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 197 (1): 35–37.
5. Cowans NJ, Spencer K. 2007. First trimester ADAM12 and PAPP‐A as markers for intrauterine fetal growth through their roles in the insulin‐like growth factor system. Prenat Diagn 27 (3): 264–271.
6. De Jong CL, Francis A, Van Geijn HP, Gardosi J. 2000. Customized fetal weight limits for antenatal detection of fetal growth restriction. Ultrasound Obstet Gynecol 15 (1): 36–40.
7. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First‐trimester maternal serum PAPP‐A and free‐beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population‐based screening study (the FASTER Trial). Am J Obstet Gynecol 191 (4): 1446–1451.
8. Dugoff L, Lynch AM, Cioffi‐Ragan D, et al. 2005. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet Gynecol 193 (3Pt2): 1208–1212.
9. Newburn‐Cook CV, Onyskiw JE. 2005. Is older maternal age a risk factor for preterm birth and fetal growth restriction? A systematic review. Health Care Women Int 26 (9): 852–875.
10. Newnham J. 1998. Consequences of fetal growth restriction. Curr Opin Obstet Gynecol 10 (2): 145–149.
11. Nicolaides KH, Bindra R, Turan OM, et al. 2006. A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound. Ultrasound Obstet Gynecol 27 (1): 13–17.
12. Rich‐Edwards JW, Colditz GA, Stampfer MJ, et al. 1999. Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 130 (4Pt1): 278–284.
13. Spencer K, Bindra R, Nicolaides KH. 2003. Maternal weight correction of maternal serum PAPP‐A and free β‐hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23: 851–855.
14. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. 2005. Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free beta‐hCG and with second‐trimester uterine artery Doppler. Prenat Diagn 25 (10): 949–953.
15. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. 2007. First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsia. Ultrasound Obstet Gynecol 29 (2): 128–134.
16. Vielwerth SE, Jensen RB, Larsen T, Greisen G. 2007. The impact of maternal smoking on fetal and infant growth. Early Hum Dev 83 (8): 491–495.
17. Wolfe HM, Zador IE, Gross TL, Martier SS, Sokol RJ. 1991. The clinical utility of maternal body mass index in pregnancy. Am J Obstet Gynecol 164 (5Pt1): 1306–1310.
18. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. 1987. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 15 (1): 45–52.